08:00 , Nov 19, 2012 |  BC Week In Review  |  Company News

Arrayit diagnostic, supply/service news

Arrayit said it expects to distribute 19.4 million shares, or a 60% stake, in its Arrayit Diagnostics Inc. subsidiary as a dividend to shareholders on Jan. 15. Arrayit will distribute one Arrayit Diagnostics share for...
07:00 , Oct 8, 2012 |  BC Week In Review  |  Financial News

Arrayit proposes private placement

Arrayit Corp. (OTCBB:ARYC), Sunnyvale, Calif.   Business: Microarrays, Diagnostic, Supply/Service   Date announced: 10/4/12   Type: Private placement   To be raised: Up to $8 million   Shares: TBD   Price prior: $0.19   Shares...
07:00 , Apr 23, 2012 |  BC Week In Review  |  Clinical News

OvaDx diagnostic data

In a U.S. pilot study in 69 patients with ovarian cancer, 10 patients with benign conditions and 178 matched healthy controls showed that OvaDx had a sensitivity and specificity of 79.7% and 100%, respectively, for...
08:00 , Dec 19, 2011 |  BC Week In Review  |  Company News

Arrayit diagnostic, supply/service news

Arrayit said it would distribute its 19.4 million shares, or 78.18% stake, in its Arrayit Diagnostics Inc. subsidiary as a dividend to existing shareholders. The dividend distribution date and details will be announced next quarter....
08:00 , Dec 14, 2009 |  BC Week In Review  |  Company News

Arrayit, Wayne State University deal

Arrayit's Arrayit Diagnostics Inc. subsidiary received an exclusive, worldwide license to develop and commercialize a diagnostic using the university's IP covering undisclosed biomarkers for ovarian cancer. The test will screen for early stage ovarian cancer...
07:00 , Oct 13, 2008 |  BC Week In Review  |  Company News

Biosystems International, Integrated Media Holdings Inc. deal

Integrated Media's Arrayit Co. business received an exclusive, worldwide license to use BioSystems' Plasma Scan antibody library to develop microarrays to identify proteins expressed in human plasma. The microarrays will be developed as diagnostics. The...